Impella heart pump in heart attack with shock
Part of Heart & circulation clinical trials.
This study looks at how well the Impella CP heart pump works for people who have a severe heart attack that causes their heart to pump too weakly to keep blood flowing to their body. It's a registry that follows your care to improve best practices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack within the last 36 hours.
- You have cardiogenic shock, meaning your heart can't pump enough blood to your body.
- Your shock started before or during a procedure to open blocked heart arteries.
- You are 18 years or older.
- Your main heart pump was the Impella CP device (not a different type of pump).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump (Impella device) for people who have a severe heart attack and go into shock (very low blood pressure). It aims to see if the pump can help the heart recover better than standard care.
This study reviews how well people tolerated the Impella heart pump during cardiogenic shock and what complications occurred. It looks at past cases from 2010 to 2022 to help doctors understand the safety of this device.
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
This trial tests whether switching to a more powerful heart pump (Impella 5.5) within 24 hours of a heart attack helps people whose hearts are still struggling despite a standard pump. It may be an option for patients who had a heart attack, received an Impella CP pump, but still need strong medication to keep blood flowing.
This study is for people in the intensive care unit who are using a heart pump called Impella. It will collect information about how well the heart pumps blood during treatment to help doctors learn more.
This study examines detailed data from patients who received an Impella 5.5 heart pump to treat cardiogenic shock—a life-threatening condition where the heart cannot pump enough blood. Researchers use advanced computer analysis to understand what helps patients recover best.
Hear when a new AMI Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.